VitaNova Life Sciences Corporation (YJGJD) Stock Price, News & Analysis
Company Description
VitaNova Life Sciences Corporation (YJGJD) is classified in the medical distribution industry within the Healthcare sector.
For FY2025, VitaNova Life Sciences Corporation reported revenue of $2.7M with net income of $851K and diluted earnings per share of $0.03. The company operates at a net profit margin of 32.0%.
This page collects what Stock Titan holds for YJGJD, including price data, SEC filings, and financial highlights.
YJGJD Metrics & Rankings
Latest News
SEC Filings
VitaNova Life Sciences Corporation has filed 2 recent SEC filings, including 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all YJGJD SEC filings →
Financial Highlights
VitaNova Life Sciences Corporation generated $2.7M in revenue in FY2025, retaining a 59.2% gross margin, operating income reached $1.2M (45.4% operating margin), and net income was $851K, reflecting a 32.0% net profit margin. Diluted earnings per share stood at $0.03. The company generated $193K in operating cash flow. The current ratio was 5.90, measuring current assets divided by current liabilities.
Upcoming Events
YJGJD Company Profile & Sector Positioning
VitaNova Life Sciences Corporation (YJGJD) operates in the Medical Distribution industry within the broader Healthcare sector.
Investors comparing YJGJD often look at related companies in the same sector, including Amplifon SPA (AMFPY), Gold Entmt Group Inc (GEGP), Nass VY Gateway Ltd (NSVGF), Essilor Lxttca (ESLOY), and Siemens Healthineers (SMMNY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate YJGJD's relative position within its industry.